On September 3, 2024 INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, reported that management will participate in the following investor conferences in September and October, 2024 (Press release, INmune Bio, SEP 3, 2024, View Source [SID1234646295]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird 2024 Global Healthcare Conference

New York, NY; September 10-11, 2024
Presentation Time: Tuesday, September 10 at 8:30-9:00 AM Eastern Time
Location: Session III, Empire Ballroom B, Mezzanine Level